IN2014MU01191A - - Google Patents

Info

Publication number
IN2014MU01191A
IN2014MU01191A IN1191MU2014A IN2014MU01191A IN 2014MU01191 A IN2014MU01191 A IN 2014MU01191A IN 1191MU2014 A IN1191MU2014 A IN 1191MU2014A IN 2014MU01191 A IN2014MU01191 A IN 2014MU01191A
Authority
IN
India
Prior art keywords
anagliptin
preparation
short
relates
present
Prior art date
Application number
Other languages
English (en)
Inventor
Naveen Reddy
Damodara Naidu
Pramodkumar Sharma
Bhatraju Srinivasa Rao
Keshav Deo
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1191MU2014 priority Critical patent/IN2014MU01191A/en
Priority to PCT/IB2014/066940 priority patent/WO2015150887A1/en
Publication of IN2014MU01191A publication Critical patent/IN2014MU01191A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1191MU2014 2014-03-29 2014-12-16 IN2014MU01191A (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1191MU2014 IN2014MU01191A (pt) 2014-03-29 2014-12-16
PCT/IB2014/066940 WO2015150887A1 (en) 2014-03-29 2014-12-16 Process for the preparation of anagliptin or its salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1191MU2014 IN2014MU01191A (pt) 2014-03-29 2014-12-16

Publications (1)

Publication Number Publication Date
IN2014MU01191A true IN2014MU01191A (pt) 2015-10-02

Family

ID=54239455

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1191MU2014 IN2014MU01191A (pt) 2014-03-29 2014-12-16

Country Status (2)

Country Link
IN (1) IN2014MU01191A (pt)
WO (1) WO2015150887A1 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100998796B1 (ko) 2003-01-31 2010-12-06 가부시키가이샤산와카가쿠켄큐쇼 디펩티딜 펩티다아제 ｉｖ를 저해하는 화합물
EP1833480A2 (en) 2004-11-30 2007-09-19 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
WO2009047240A1 (en) 2007-10-09 2009-04-16 Smithkline Beecham Corporation Indole derivatives useful as ppar activators
JP2010064982A (ja) 2008-09-10 2010-03-25 Dainippon Sumitomo Pharma Co Ltd アルキルアミノ誘導体
AR077468A1 (es) 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
EP2473488A4 (en) 2009-09-04 2013-07-17 Zalicus Pharmaceuticals Ltd SUBSTITUTED HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF PAIN AND EPILEPSY
WO2011075699A2 (en) 2009-12-18 2011-06-23 Sunovion Pharmaceuticals Inc. Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
TW201412745A (zh) * 2012-08-28 2014-04-01 Sanwa Kagaku Kenkyusho Co Ｎ－［２－（｛２－［（２Ｓ）－２－氰基吡咯啶－１－基］－２－側氧乙基｝胺基）－２－甲基丙基］－２－甲基吡唑并［１，５－ａ］嘧啶－６－甲醯胺之結晶

Also Published As

Publication number Publication date
WO2015150887A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
IN2014CH00247A (pt)
IN2013MU00646A (pt)
HUE053858T2 (hu) Eljárás diének elõállítására
MX2017003301A (es) Producto refractario, relleno para fabricar el producto, procedimiento para fabricar el producto y uso del producto refractario.
EP3237424A4 (en) Process of making cenicriviroc and related analogs
GB201509646D0 (en) Novel process
SG11201608513WA (en) Novel purification process of gonadotropin
IL248267A0 (en) A process for preparing converted cycloserines
MX2017011389A (es) Proceso para la preparacion de 3-cloro-2-vinilfenilsulfonatos.
HUE055687T2 (hu) Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására
MX2016015624A (es) Proceso para la preparacion de derivados de tiazol.
PH12017500499A1 (en) Synthesis of ent-progesterone and intermediates thereof
PL3271325T3 (pl) Sposób wytwarzania (S)-metolachloru
PL3182981T3 (pl) Sposób wytwarzania izomaltooligosacharydów
GB201416909D0 (en) Method of forming concentrated solution
MX2019003584A (es) Proceso para la preparacion de la forma i de anhidrato de boscalid y la forma ii de anhidrato de boscalid.
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
GB201607540D0 (en) Hydrcarbon production process
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
WO2015118558A3 (en) Process for the preparation of clofarabine
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
MX2021000509A (es) Extracto concentrado de sabadilla.
HUE039419T2 (hu) Eljárás ramipril elõállítására
IN2014MU01191A (pt)
MX2018001296A (es) Proceso para la sintesis de ravidasvir.